These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1722164)

  • 41. Benign prostatic hyperplasia.
    Chisholm GD; Khan MS
    Practitioner; 1992 Mar; 236(1512):325-7. PubMed ID: 1378611
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment options in benign prostatic hypertrophy.
    Stone NN
    Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data.
    Herrmann TR; Georgiou A; Bach T; Gross AJ; Oelke M
    Minerva Urol Nefrol; 2009 Sep; 61(3):309-24. PubMed ID: 19773731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What will replace TURP?
    Brawer MK; McConnell JD; Oesterling JE
    Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical management of benign prostatic hyperplasia with androgen suppression.
    McConnell JD
    Prostate Suppl; 1990; 3():49-59. PubMed ID: 1689170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and Efficacy of Thulium Laser Prostatectomy Versus Transurethral Resection of Prostate for Treatment of Benign Prostate Hyperplasia: A Meta-Analysis.
    Jiang H; Zhou Y
    Low Urin Tract Symptoms; 2016 Sep; 8(3):165-70. PubMed ID: 27619781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
    Steele GS; Sleep DJ
    J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia.
    Long Z; Zhang YC; He LY; Zhong KB; Tang YX; Huang K
    Asian J Surg; 2014 Apr; 37(2):58-64. PubMed ID: 23726830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results].
    Kanimoto Y; Okada K
    Hinyokika Kiyo; 1991 Nov; 37(11):1423-8. PubMed ID: 1722627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benign prostatic hyperplasia. Hormonal treatment.
    McConnell JD
    Urol Clin North Am; 1995 May; 22(2):387-400. PubMed ID: 7539183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selection of the surgical procedure for management of benign prostatic hyperplasia.
    Mebust WK
    Prog Clin Biol Res; 1994; 386():369-84. PubMed ID: 7528405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in the treatment of benign prostatic hyperplasia.
    Lai MK
    J Formos Med Assoc; 1996 Nov; 95(11):822-7. PubMed ID: 8990768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
    Coogan CL; Bostwick DG; Bloom KJ; Gould VE
    Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical management of benign prostatic hyperplasia.
    Kane MM; Fields DW; Vaughan ED
    Urology; 1990 Nov; 36(5 Suppl):5-12. PubMed ID: 1700530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term clinical reliability of transurethral and open prostatectomy for benign prostatic obstruction: a term of comparison for nonsurgical procedures.
    Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Matozzo V; Barbieri L; Rigatti P
    Eur Urol; 1993; 23(2):262-6. PubMed ID: 7683984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Benign prostatic hyperplasia--choice of therapy in the elderly].
    Schultze-Seemann W
    Fortschr Med; 1993 Sep; 111(25):394-7. PubMed ID: 7691697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study.
    Perimenis P; Gyftopoulos K; Markou S; Barbalias G
    Urology; 2002 Mar; 59(3):373-7. PubMed ID: 11880073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.